News Image

CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) - A Strong Candidate for Affordable Growth Investors

By Mill Chart

Last update: May 15, 2025

CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) stands out as an affordable growth stock based on its strong fundamentals. The company, which focuses on rare disease treatments, combines solid growth with reasonable valuation, making it an interesting option for investors seeking growth at a sensible price.

CATALYST PHARMACEUTICALS stock chart

Growth Prospects

CPRX has demonstrated impressive growth metrics:

  • Earnings Per Share (EPS) surged by 143.24% in the past year.
  • Revenue grew 23.49% year-over-year, with a three-year average growth rate of 36.89%.
  • Future EPS growth is projected at 29.57% annually, while revenue is expected to expand by 11.94% per year.

These figures place CPRX well above industry averages, earning it a Growth Rating of 9/10.

Valuation

Despite its strong growth, CPRX remains reasonably priced:

  • The P/E ratio of 13.00 is below both the S&P 500 average (24.85) and the biotechnology industry average (61.82).
  • 94.66% of industry peers have a higher forward P/E ratio than CPRX’s 13.68.
  • The stock’s Enterprise Value/EBITDA and Price/Free Cash Flow ratios also indicate undervaluation relative to competitors.

With a Valuation Rating of 7/10, CPRX offers an attractive entry point.

Profitability and Financial Health

CPRX excels in profitability and financial stability:

  • Profit Margin (33.33%) and Operating Margin (39.68%) rank among the best in the industry.
  • Return on Equity (22.52%) and Return on Assets (19.25%) outperform most peers.
  • The company has no debt, contributing to a strong Health Rating of 8/10.

Conclusion

CPRX presents a compelling mix of growth, value, and financial strength. Investors looking for affordable growth opportunities in the biotech sector may find this stock worth further research.

For more details, review the full fundamental analysis of CPRX.

Our Affordable Growth screener lists more stocks with similar characteristics and is updated daily.

Disclaimer

This is not investing advice. Always conduct your own research before making investment decisions.

CATALYST PHARMACEUTICALS INC

NASDAQ:CPRX (6/4/2025, 8:16:16 PM)

After market: 25.4495 +0.16 (+0.63%)

25.29

+0.38 (+1.53%)



Find more stocks in the Stock Screener

CPRX Latest News and Analysis

ChartMill News Image19 hours ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) – A Strong Contender for CANSLIM Investors

CATALYST PHARMACEUTICALS (CPRX) meets CANSLIM criteria with strong earnings growth, high relative strength, and solid fundamentals. A technical uptrend and reasonable valuation add to its appeal.

ChartMill News Image3 days ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) – A Strong Contender for Growth Investors

CATALYST PHARMACEUTICALS INC (CPRX) meets key growth criteria from Louis Navellier’s strategy, with strong earnings, revenue growth, and solid financial health. A detailed analysis highlights its potential for investors.

ChartMill News Image12 days ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) – A Strong Contender for Quality Investors

Catalyst Pharmaceuticals (CPRX) shows strong fundamentals, high profitability, and zero debt, making it a compelling choice for quality investors. The stock trades at reasonable valuations with solid growth prospects.

ChartMill News Image15 days ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) – A Strong Growth Stock with Technical Breakout Potential

CATALYST PHARMACEUTICALS (CPRX) shows strong growth, profitability, and a bullish technical setup, making it a stock to watch in the biotech sector.

ChartMill News Image17 days ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) - A High Growth Momentum Stock with Strong Technical Setup

CATALYST PHARMACEUTICALS (CPRX) shows strong earnings momentum and a bullish technical setup, making it a candidate for high-growth investors.

ChartMill News Image21 days ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) - A Strong Candidate for Affordable Growth Investors

CATALYST PHARMACEUTICALS (CPRX) offers strong growth, solid profitability, and reasonable valuation, making it an attractive option for investors seeking affordable growth stocks in biotech.

ChartMill News Image21 days ago - ChartmillCATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) is a candidate for high growth investors. Here's why.

A fundamental and technical analysis of (NASDAQ:CPRX): Why CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) is Poised for High Growth.

Follow ChartMill for more